Motion Sickness: Clinical Trials

2 trials for Motion Sickness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2

Follow Motion Sickness: new trials by email Literature Review of Motion Sickness trials Research Report on Motion Sickness

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
DPI-386 Nasal Gel, Placebo Nasal Gel - Motion Sickness, Space, Motion Sickness
Phase 2UnknownRepurposed Therapeutics, Inc.302022-01-212024-05-17
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
DPI-386 Nasal Gel, Other (e.g., promethazine, meclizine) - Motion Sickness, Space, Motion Simulation
Phase 2UnknownRepurposed Therapeutics, Inc.802021-08-102024-05-16

Narrower conditions

Space Motion Sickness (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)

Interventions

Scopolamine (2)  ·  Meclizine (1)  ·  Promethazine (1)

Sponsors

Repurposed Therapeutics, Inc. (2)

Countries

United States (2)

Top investigators

Scott J Wood, PhD (2)